Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development

Dean Fennell, R.M. Rudd

Research output: Contribution to journalArticle

67 Citations (Scopus)
Original languageEnglish
Pages (from-to)354-362
Number of pages9
JournalLancet Oncology
Volume5(6)
Issue number6
Publication statusPublished - 01 Jun 2004

Cite this

@article{b7229a4230dc49c793318638ef803809,
title = "Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development",
author = "Dean Fennell and R.M. Rudd",
year = "2004",
month = "6",
day = "1",
language = "English",
volume = "5(6)",
pages = "354--362",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. / Fennell, Dean; Rudd, R.M.

In: Lancet Oncology, Vol. 5(6), No. 6, 01.06.2004, p. 354-362.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development

AU - Fennell, Dean

AU - Rudd, R.M.

PY - 2004/6/1

Y1 - 2004/6/1

UR - http://www.scopus.com/inward/record.url?scp=2542443539&partnerID=8YFLogxK

M3 - Article

VL - 5(6)

SP - 354

EP - 362

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 6

ER -